Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Long-term follow-up of people with multiple myeloma from a GMMG therapy study

Collects long-term follow-up data on adults with multiple myeloma from a therapy study.

Plain-language title generated from the registry record
Registry title: GMMG Multiple Myeloma Registry

Key facts

Where
Berlin, Bielefeld, Bochum, Bonn, Chemnitz, Cologne, Darmstadt, Düsseldorf, Erlangen, Essen, Frankfurt am Main, Giessen, Hagen, Hamburg, Heidelberg, Heilbronn, Homburg, Kaiserslautern, Koblenz, Lebach, Mainz, Mannheim, Marburg, Mönchengladbach, Regensburg, Schwäbisch Hall, Siegburg, Speyer, Trier, and Tübingen, GermanySee the 35 sites

Where in Germany

  • Charité Campus Benjamin Franklin, III. Med. Abt. (Hämatologie/Onkologie)Berlin, GermanyTaking people
  • HELIOS Klinikum, Klinik für Hämatologie, Onkologie und ImmunologieBerlin, GermanyTaking people
  • Klinikum Bielefeld, Klinik für Hämatologie, Onkologie und PalliativmedizinBielefeld, GermanyTaking people
  • Medizinische Universitätsklinik, KnappschaftskrankenhausBochum, GermanyTaking people
  • Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik III, Schwerpunkt Onkologie, Hämatologie und RheumatologieBonn, GermanyTaking people
  • Klinikum Chemnitz GmbH, Innere Medizin IIIChemnitz, GermanyTaking people
  • Universitätsklinikum Köln, Klinik I - Innere MedizinCologne, GermanyTaking people
  • Klinikum Darmstadt, Med. Klinik V, Hämatologie/OnkologieDarmstadt, GermanyTaking people
  • Onkologisches Studienzentrum DarmstadtDarmstadt, GermanyTaking people
  • Universitätsklinikum Düsseldorf, Klinik für Hämatologie,Onkologie und Klin. ImmunologieDüsseldorf, GermanyTaking people
  • Universitätsklinik ErlangenErlangen, GermanyTaking people
  • Ev. Krankenhaus Essen-Werden gGmbH, Zentrum für Innere Medizin, Klinik für Hämatologie, Onkologie und StammzelltransplantationEssen, GermanyTaking people
  • Universitätsklinikum Essen, Klinik für Hämatologie und StammzelltransplantationEssen, GermanyTaking people
  • Universitätsklinikum Frankfurt, Goethe-Universität Medizinische Klinik IIFrankfurt am Main, GermanyTaking people
  • Justus-Liebig-Universität, Medizinische Klinik IVGiessen, GermanyTaking people
  • Kath. Krankenhaus Hagen GmbH, Abt. Hämatologie/OnkologieHagen, GermanyTaking people
  • Asklepios Klinik Hamburg Altona, II. Med. KlinikHamburg, GermanyTaking people
  • Onkologische SchwerpunktpraxisHeidelberg, GermanyTaking people
  • University Hospital Heidelberg, Med. Klinik VHeidelberg, GermanyTaking people
  • SLK Kliniken Heilbronn, Med. Klinik IIIHeilbronn, GermanyTaking people
  • Universitätsklinikum des Saarlandes, Innere Medizin IHomburg, GermanyTaking people
  • Westpfalz-Klinikum GmbHKaiserslautern, GermanyTaking people
  • Praxisklinik für Hämatologie und OnkologieKoblenz, GermanyTaking people
  • Onkologisches Zentrum, Gemeinschaftspraxis f. Hämatologie u. Onkologie im Caritas KHLebach, GermanyTaking people
  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz, III. Med. KlinikMainz, GermanyTaking people
  • III. Medizinische Klinik Hämatologie und Internistische OnkologieMannheim, GermanyTaking people
  • Mannheimer Onkologie PraxisMannheim, GermanyTaking people
  • Philipps-Universität Marburg, Hämatologie/Onkologie/ImmunologieMarburg, GermanyTaking people
  • Krankenhaus Maria Hilf GmbH, Franziskuskrankenhaus, Med. Klinik IMönchengladbach, GermanyTaking people
  • Krankenhaus Barmherzige Brüder, Klinik für Onkologie und HämatologieRegensburg, GermanyTaking people
  • Diakonie-Klinikum Schwäbisch Hall gGmbH, Innere Medizin IIISchwäbisch Hall, GermanyTaking people
  • ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort SiegburgSiegburg, GermanyTaking people
  • Diakonissen-Stiftungs-Krankenhaus SpeyerSpeyer, GermanyTaking people
  • Klinikum Mutterhaus der Borromäerinnen gGmbHTrier, GermanyTaking people
  • University Hospital Tübingen, Med. Klinik und Poliklinik, Abt. IITübingen, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Prof. Dr. Hartmut Goldschmidt
Trial code
NCT07111884
Record updated
8 August 2025
Original description
The goal of this observational study is to collect long-term clinical follow-up data on patients with multiple myeloma who participated in a therapy study of the German-Speaking Myeloma Multicenter Group (GMMG). Target variables of interest are:Read full original descriptionShow less

National, Observational, Non-interventional, Retro- and Prospective Clinical Multiple Myeloma Registry GMMG

The goal of this observational study is to collect long-term clinical follow-up data on patients with multiple myeloma who participated in a therapy study of the German-Speaking Myeloma Multicenter Group (GMMG). Target variables of interest are:

Overall survival, progression-free survival and follow-up time.

The relevant registry data will be provided and evaluated together with the therapy study data for scientific research projects.

This allows seamless documentation of patient data from the end of the trial to long-term follow-up.

Inclusion: Previous participation in a a therapy study of the GMMG study group.

Exclusion: patients with organ amyloidosis at time of diagnosis.

ClinicalTrials.gov NCT07111884